Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Ani Pharmaceuticals (ANIP) FCF Payout Ratio (2021 - 2025)

Historic FCF Payout Ratio for Ani Pharmaceuticals (ANIP) over the last 5 years, with Q3 2025 value amounting to 0.01.

  • Ani Pharmaceuticals' FCF Payout Ratio fell 8289.43% to 0.01 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.01, marking a year-over-year decrease of 5258.12%. This contributed to the annual value of 0.03 for FY2024, which is 13040.75% up from last year.
  • Latest data reveals that Ani Pharmaceuticals reported FCF Payout Ratio of 0.01 as of Q3 2025, which was down 8289.43% from 0.01 recorded in Q2 2025.
  • Ani Pharmaceuticals' 5-year FCF Payout Ratio high stood at 0.35 for Q3 2022, and its period low was 0.05 during Q4 2022.
  • In the last 5 years, Ani Pharmaceuticals' FCF Payout Ratio had a median value of 0.01 in 2025 and averaged 0.03.
  • In the last 5 years, Ani Pharmaceuticals' FCF Payout Ratio tumbled by 25638.29% in 2022 and then soared by 29715.48% in 2024.
  • Ani Pharmaceuticals' FCF Payout Ratio (Quarter) stood at 0.02 in 2021, then crashed by 256.38% to 0.05 in 2022, then surged by 117.71% to 0.01 in 2023, then skyrocketed by 215.32% to 0.03 in 2024, then plummeted by 69.94% to 0.01 in 2025.
  • Its last three reported values are 0.01 in Q3 2025, 0.01 for Q2 2025, and 0.01 during Q1 2025.